id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0150-0021,FDA,FDA-2008-D-0150,Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,Other,Guidance,2022-12-15T05:00:00Z,2022,12,2022-12-15T05:00:00Z,,2024-11-12T23:16:26Z,,1,0,090000648430862c
FDA-2008-D-0150-0020,FDA,FDA-2008-D-0150,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2017-05-30T04:00:00Z,2017,5,2017-05-30T04:00:00Z,,2017-05-30T14:38:05Z,2017-11011,0,0,09000064826680d2
FDA-2008-D-0150-0019,FDA,FDA-2008-D-0150,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims",Notice,Notice of Approval,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T17:20:33Z,2013-30146,0,0,09000064814cb007
FDA-2008-D-0150-0018,FDA,FDA-2008-D-0150,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,Notice,General Notice,2013-08-22T04:00:00Z,2013,8,2013-08-22T04:00:00Z,2013-09-24T03:59:59Z,2013-08-22T14:23:12Z,2013-20471,0,0,09000064813bf008
FDA-2008-D-0150-0017,FDA,FDA-2008-D-0150,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,Notice,General Notice,2013-04-18T04:00:00Z,2013,4,2013-04-18T04:00:00Z,2013-06-18T03:59:59Z,2014-01-14T13:21:01Z,2013-09093,0,0,0900006481299b1d
FDA-2008-D-0150-0015,FDA,FDA-2008-D-0150,"Guidance for Industry; Availability: Hypertension Indication, Drug Labeling for Cardiovascular Outcome Claims",Notice,NAD-Notice of Availability of Data,2011-03-15T04:00:00Z,2011,3,2011-03-15T04:00:00Z,2011-05-17T03:59:59Z,2011-03-16T12:35:04Z,2011-05945,0,0,0900006480c07f51
FDA-2008-D-0150-0016,FDA,FDA-2008-D-0150,"Guidance for Industry; Hypertension Indication, Drug Labeling for Cardiovascular Outcome Claims",Other,GDL-Guidance (Supporting and Related Materials),2011-03-15T04:00:00Z,2011,3,2011-03-15T04:00:00Z,,2011-03-16T12:39:53Z,,0,0,0900006480c081c0
FDA-2008-D-0150-0001,FDA,FDA-2008-D-0150,Draft Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims; Availability,Notice,NAD-Notice of Availability of Data,2008-03-13T04:00:00Z,2008,3,2008-03-13T04:00:00Z,2008-05-13T03:59:59Z,2008-05-12T07:28:00Z,E8-05083,0,0,09000064803f402e
FDA-2008-D-0150-0002,FDA,FDA-2008-D-0150,Draft Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims - Guidance Document,Other,,2008-03-13T00:00:00Z,2008,3,,,2020-01-29T20:57:08Z,,0,1,09000064803f416f